Healthcare & Life Sciences
Biolojic Design
Israel
series-a
series-a
Stage
1
Investors
About
Biolojic Design uses computational methods including 3D modeling and machine learning to design and engineer novel therapeutic antibodies targeting autoimmune diseases and immuno-oncology.
Explore Biolojic Design's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.